Fellow and Director of Clinical Studies St John’s College, Cambridge
MA, MB, BChir, MSc, MD, FRCPCH. FRCP, FRCGP, FMedSci
Tel: 01223 330562
Ann Louise Kinmonth studied for her MD in the University Department of Paediatrics in Oxford, completed her vocational training in the Berinsfield Practice in 1982 and moved to a Principalship in General Practice at the Aldermoor Health Centre in Southampton in 1983. She was Lecturer, Senior Lecturer, Reader and Professor in Primary Medical Care in the University of Southampton between 1983 and 1996 and moved to the University of Cambridge in 1997.
Research interests include the prevention and management of diabetes and cardiovascular disease patient-centred care, and trials of complex behavioural interventions.
|Simmons RK, Echouffo-Tcheugui JB, Sharp SJ, Sargeant LA, Williams KM, Prevost AT, Kinmonth AL, Wareham NJ, Griffin SJ. Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial. Lancet. 2012 Oct 3. pii: S0140-6736 (12) 61422-6. doi: 10.1016/S0140-6736(12)61422-6.|
Barakat A, Williams KM, Prevost AT, Kinmonth AL, Wareham NJ, Griffin SJ, Simmons RK. Changes in physical activity and modelled cardiovascular risk following diagnosis of diabetes: 1-year results from the ADDITION-Cambridge trial cohort. Diabet Med. 2012 Aug 22. doi: 10.1111/j.1464-5491.2012.03765.x.
Hollands GJ, Whitwell SC, Parker RA, Prescott NJ, Forbes A, Sanderson J, Mathew CG, Lewis CM, Watts S, Sutton S, Armstrong D, Kinmonth AL, Prevost AT, Marteau TM. Effect of communicating DNA based risk assessments for Crohn’s disease on smoking cessation: randomised controlled trial. BMJ. 2012 Jul 20;345:e4708. doi: 10.1136/bmj.e4708.
Walter FM, Morris HC, Humphrys E, Hall PN, Prevost AT, Burrows N, Bradshaw L, Wilson EC, Norris P, Walls J, Johnson M, Kinmonth AL, Emery JD. Effect of adding a diagnostic aid to best practice to manage suspicious pigmented lesions in primary care: randomised controlled trial BMJ. 2012 Jul 4;345:e4110. doi: 10.1136/bmj.e4110.
Charles M, Simmons RK, Williams KM, Roglic G, Sharp SJ, Kinmonth AL, Wareham NJ, Griffin SJ. Cardiovascular risk reduction following diagnosis of diabetes by screening: 1-year results from the ADDITION-Cambridge trial cohort. Br J Gen Pract. 2012 Jun;62(599):e396-402.
Orrow G, Kinmonth AL, Sanderson Simon, Sutton SR. Effectiveness of physical activity promotion based in primary care: systematic review and meta-analysis of randomised controlled trials. BMJ 2012; 344:7.Farmer A, Hardeman W, Hughes D, Prevost AT, Kim Y, Craven A, Oke J, Boase S, Selwood M, Kellar I, Graffy J, Griffin S, Sutton S, Kinmonth AL. An explanatory randomised controlled trial of a nurse-led, consultation-based intervention to support patients with adherence to taking glucose lowering medication for type 2 diabetes. BMC Family Practice 2012; 13(1) : 30. http://www.biomedcentral.com/1471-2296/13/30
Griffin S, Simmons R, Williams K, Prevost A, Hardeman W, Grant J, Whittle F, Boase S, Hobbis I, Brage S, Westgate K, Fanshawe T, Sutton S, Wareham N, Kinmonth AL, Study team TA. Protocol for the ADDITION-Plus study: a randomised controlled trial of an individually-tailored behaviour change intervention among people with recently diagnosed type 2 diabetes under intensive UK general practice care. BMC Public Health 2011; 11(1) : 211. http://www.biomedcentral.com/1471-2458/11/211
Hardeman W, Kinmonth AL, Michie S, Sutton S. Theory of planned behaviour cognitions do not predict self-reported or objective physical activity levels or change in the ProActive trial. British Journal of Health Psychology 2011; 16(1) : 135-150. http://dx.doi.org/10.1348/135910710X523481
Paddison CAM, Eborall HC, French DP, Kinmonth AL, Prevost AT, Griffin SJ, Sutton S. Predictors of anxiety and depression among people attending diabetes screening: A prospective cohort study embedded in the ADDITION (Cambridge) randomized control trial. British Journal of Health Psychology 2011; 16(1) : 213-226. http://dx.doi.org/10.1348/135910710X495366